Short Interest in Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Expands By 20.0%

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) was the target of a significant increase in short interest in November. As of November 15th, there was short interest totalling 600 shares, an increase of 20.0% from the October 31st total of 500 shares. Based on an average trading volume of 400 shares, the days-to-cover ratio is presently 1.5 days.

Mosaic ImmunoEngineering Price Performance

Shares of CPMV stock opened at $1.00 on Friday. The firm has a fifty day moving average of $0.91 and a two-hundred day moving average of $0.77. The firm has a market cap of $7.24 million, a P/E ratio of -6.67 and a beta of 0.01. Mosaic ImmunoEngineering has a 1-year low of $0.10 and a 1-year high of $1.13.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.